Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
cough and cold prep a ra tions 33%<br />
anti rheu ma tics top i cal 24%<br />
an ti his ta mines sys temic 8%<br />
renin-an gio ten sin sys tem agents 7%<br />
an ti bi ot ics, sulphonamides and antivirals top i cal<br />
6%<br />
Lead ing Dose Forms:<br />
tab lets 27%<br />
gels/sols 24%<br />
pow ders/gran ules 19%<br />
coated tab lets 9%<br />
cap sules 8%<br />
NOVARTIS<br />
Full Name: Novartis Pharma Ser vices AG<br />
Street Ad dress: 29, Bereznyakovskaya St.,<br />
02098 Kiev<br />
Tel: +380 44 490 53 38<br />
Fax: +380 44 490 53 39<br />
De scrip tion: Rep re sen ta tive of fice.<br />
Con tacts (Pharm): Chair man: Irina Karakai;<br />
Gen eral Con tact: Irina Karakai<br />
NOVARTIS CON SUMER HEALTH<br />
Full Name: Novartis Con sumer Health Ser vices<br />
SA<br />
Street Ad dress: Beriaznyakovskaya St. 29, 7th<br />
floor, 02098 Kiev<br />
Tel: +380 44 496 09 50<br />
Fax: +380 44 496 09 51<br />
Phar ma ceu ti cal Sales: US$ 18-20 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 65-70%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 90-95%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
VIBROCIL (na sal prep a ra tion top i cal)<br />
TERAFLU (cold prep a ra tion with out anti-in fec tive)<br />
LAMISIL (dermatological antifungal)<br />
OTRIVIN (na sal prep a ra tion top i cal)<br />
FENISTIL (antipruritic; an ti his ta mine sys temic)<br />
Ther a peu tic Range:<br />
na sal prep a ra tions 33%<br />
cough and cold prep a ra tions 31%<br />
dermatological antifungals 16%<br />
an ti his ta mines sys temic 7%<br />
anti rheu ma tics top i cal 5%<br />
Lead ing Dose Forms:<br />
liq uids 40%<br />
pow ders/gran ules 25%<br />
gels/sols 14%<br />
creams 10%<br />
pres sur ised aero sols 3%<br />
SANDOZ<br />
Full Name: Sandoz Rep re sen ta tive Of fice<br />
Ukraine<br />
Street Ad dress: Polevaya Street, 4 fl. 24d,<br />
03056 Kiev<br />
Tel: +380 44 495 28 66/29 41<br />
Fax: +380 44 495 29 43<br />
Home Page: www.sandoz.com<br />
De scrip tion: Rep re sen ta tive of fice. Pro moter.<br />
Prod uct ranges in clude: phar ma ceu ti cal prod ucts<br />
(branded, unbranded, pre scrip tion, non-pre scrip -<br />
tion), hos pi tal pharmaceuticals, raw ma te ri als, bi -<br />
o log i cal prod ucts, bio tech nol ogy prod ucts,<br />
di etetic/nu tri tional prod ucts, herbal prod ucts,<br />
vet er i nary pharmaceuticals. Es tab lished 1993.<br />
c.300 pharmaceutical employees in 2008.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 180 (2008)<br />
Con tacts (Pharm): Chair man: Dr Ray Masch;<br />
Gen eral Con tact: Dr Ray Masch<br />
Phar ma ceu ti cal Sales: US$ 30-35 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 50-55%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 65-70%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
80-85%<br />
Prin ci pal Prod ucts:<br />
LINEX (antidiarrheal mi cro-or gan ism)<br />
PERSEN (hyp notic/sed a tive)<br />
OSPAMOX (pen i cil lin broad spec trum)<br />
BRONCHO MUNAL (vac cine other)<br />
AMOKSIKLAV 2X (pen i cil lin broad spec trum)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 23%<br />
antidiarrheals, elec tro lyte re plac ers, in tes ti nal<br />
anti-inflammatorie s 17%<br />
psycholeptics 14%<br />
vac cines 8%<br />
urologicals 7%<br />
Lead ing Dose Forms:<br />
cap sules 35%<br />
coated tab lets 27%<br />
tab lets 8%<br />
liq uids 7%<br />
am poules 6%<br />
UNITED ARAB EMIRATES<br />
NOVARTIS<br />
Full Name: Novartis Pharma Ser vices AG<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 219